New SEC Form D filing
Lexaria Bioscience Corp., 2026-09-21
A new SEC Form D private-offering notice from Kelowna, BC, Canada, a $113,492 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Lexaria Bioscience Corp. Verified via SEC Form D
Filed 2026-09-21Filed to raise $113,492First money in 2026-09-09Raised so far $113,492HQ (as filed) Kelowna, BC, CanadaSector Biotech machine-classified from the filing aloneStage (inferred) Pre-seedCall status Non-US principal office
Source linked the Form D on EDGAR↗Named in the filing 8 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Monocacy Therapeutics Inc., 2026-09-21, $49, Monrovia, MD
- 3Helix, Inc., 2026-09-21, $10M, Salt Lake City, UT
- Avery Therapeutics, Inc., 2026-09-21, $15.4M, Tucson, AZ
- BioStem Technologies, Inc., 2026-09-21, $40M, Pompano Beach, FL
- Jupiter Biomedical Research, Inc., 2026-09-21, $1M, Palm Beach Gardens, FL
- Vicora, Inc., 2026-09-18, $2.5M, Buffalo, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.